
ASML reported robust second-quarter results, exceeding analyst estimates with EPS of $5.90 and revenue of $7.69 billion, and provided Q3 2025 revenue guidance between $7.40 billion and $7.90 billion. Despite this earnings beat, the company's shares declined over 7% as it withdrew its confirmation of 2026 growth targets, signaling potential headwinds or a more cautious long-term outlook that overshadowed the strong immediate performance.
ASML reported a solid second quarter, with earnings per share of $5.90 and revenue of $7.69 billion, surpassing consensus estimates of $5.15 and $7.54 billion, respectively. Despite this outperformance, the company's shares declined over 7% due to a significant change in its forward-looking statements. The primary catalyst for the negative market reaction was the company's decision to no longer confirm its 2026 growth targets, introducing considerable uncertainty into its long-term outlook. This cautious signal overshadowed the immediate financial strength and the provided Q3 2025 revenue guidance of $7.40 billion to $7.90 billion. The market's sharp negative response indicates that investors are placing a higher weight on future growth ambiguity than on current operational success. This sentiment is further contextualized by pre-existing analyst concerns, evidenced by ten negative EPS revisions versus only four positive revisions in the last 90 days, suggesting a deteriorating outlook even before this announcement.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment